Trial Profile
Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2023
Price :
$35
*
At a glance
- Drugs Netarsudil (Primary) ; Bimatoprost
- Indications Low tension glaucoma
- Focus Therapeutic Use
- 06 Aug 2021 New trial record